China Biologic Products has launched a follow-on offering of about US$300m, comprising 0.7m primary and 1.8m secondary shares from Warburg Pincus.... more
APAC Financial Markets • #ChinaBiologicProducts, #Equities, #FollowOn, #WarburgPincus #Equities, #Issuance/Pipeline
No comments:
Post a Comment